For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and the formulated version represents a true advancement . These groundbreaking therapies protect the transthyretin protein, halting its harmful build-up and reducing